The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.
- First select the CSR Section, then a Table/Figure from that section.
- Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.
To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 523 KB) and Technical Notes (PDF, 687 KB) pages.
Download and Print: Download Printer-friendly PDF Download data
Table 1.27
| Race/Ethnicity | Primary Site | Age-Adjusted Rateb, 2004-2008 |
Trend (APC)c, 1999-2008 |
|---|---|---|---|
| All Races | All Sites | 223.0 | -1.8* |
| Lung and Bronchus | 67.4 | -2.1* | |
| Prostate | 24.4 | -3.6* | |
| Colon and Rectum | 20.7 | -3.0* | |
| Pancreas | 12.5 | 0.4* | |
| Leukemia | 9.7 | -0.9* | |
| Non-Hodgkin Lymphoma | 8.6 | -2.8* | |
| Liver & IBDf | 7.9 | 2.6* | |
| Esophagus | 7.8 | -0.1 | |
| Urinary Bladder | 7.7 | 0.1 | |
| Kidney and Renal Pelvis | 5.9 | -0.6* | |
| Brain and ONSf | 5.2 | -1.0* | |
| Stomach | 5.2 | -3.4* | |
| Myeloma | 4.4 | -1.1* | |
| Melanoma of the Skin | 4.0 | 0.8* | |
| Oral Cavity and Pharynx | 3.9 | -1.1* | |
| White | All Sites | 220.0 | -1.7* |
| Lung and Bronchus | 66.9 | -2.0* | |
| Prostate | 22.4 | -3.4* | |
| Colon and Rectum | 20.1 | -3.2* | |
| Pancreas | 12.4 | 0.5* | |
| Leukemia | 9.9 | -0.9* | |
| Non-Hodgkin Lymphoma | 8.9 | -2.7* | |
| Urinary Bladder | 8.0 | 0.2 | |
| Esophagus | 7.9 | 0.6* | |
| Liver & IBDf | 7.2 | 2.6* | |
| Kidney and Renal Pelvis | 6.0 | -0.6* | |
| Brain and ONSf | 5.6 | -0.9* | |
| Melanoma of the Skin | 4.6 | 1.0* | |
| Stomach | 4.5 | -3.5* | |
| Myeloma | 4.2 | -1.0* | |
| Oral Cavity and Pharynx | 3.7 | -0.6* | |
| Black | All Sites | 295.3 | -2.4* |
| Lung and Bronchus | 85.4 | -2.8* | |
| Prostate | 54.9 | -3.7* | |
| Colon and Rectum | 30.5 | -1.9* | |
| Pancreas | 15.6 | -0.4 | |
| Liver & IBDf | 11.5 | 3.6* | |
| Stomach | 10.7 | -3.1* | |
| Leukemia | 8.6 | -0.5 | |
| Esophagus | 8.5 | -4.3* | |
| Myeloma | 8.2 | -1.1* | |
| Non-Hodgkin Lymphoma | 6.1 | -2.6* | |
| Kidney and Renal Pelvis | 6.0 | -0.5 | |
| Oral Cavity and Pharynx | 6.0 | -3.3* | |
| Urinary Bladder | 5.5 | -0.6 | |
| Larynx | 4.4 | -2.9* | |
| Brain and ONSf | 3.1 | -0.9 | |
| Asian/ Pacific Islander |
All Sites | 134.7 | -1.6* |
| Lung and Bronchus | 36.7 | -1.3* | |
| Liver & IBDf | 14.7 | -0.9 | |
| Colon and Rectum | 13.3 | -2.3* | |
| Prostate | 10.5 | -3.2* | |
| Stomach | 9.2 | -3.7* | |
| Pancreas | 8.4 | 0.8 | |
| Non-Hodgkin Lymphoma | 5.4 | -2.6* | |
| Leukemia | 5.0 | -1.7 | |
| Esophagus | 3.2 | -1.0 | |
| Oral Cavity and Pharynx | 3.0 | -3.1* | |
| Urinary Bladder | 2.7 | -0.8 | |
| Kidney and Renal Pelvis | 2.6 | 1.2 | |
| Brain and ONSf | 2.4 | -0.9 | |
| Myeloma | 2.1 | 1.4 | |
| Soft Tissue including Heart | 1.0 | 1.5 | |
| American Indian/ Alaska Natived |
All Sites | 190.0 | -0.4 |
| Lung and Bronchus | 50.5 | 0.0 | |
| Prostate | 20.7 | -1.1 | |
| Colon and Rectum | 19.8 | -1.3 | |
| Liver & IBDf | 11.9 | 3.1 | |
| Pancreas | 10.5 | 4.1 | |
| Kidney and Renal Pelvis | 8.9 | -1.3 | |
| Stomach | 8.5 | -4.4 | |
| Esophagus | 6.7 | 0.1 | |
| Leukemia | 6.4 | 1.4 | |
| Non-Hodgkin Lymphoma | 5.1 | -4.2 | |
| Myeloma | 4.0 | -1.7 | |
| Oral Cavity and Pharynx | 3.8 | -1.3 | |
| Urinary Bladder | 3.6 | - | |
| Brain and ONSf | 2.9 | 5.6* | |
| Larynx | 2.0 | - | |
| Hispanice | All Sites | 149.1 | -2.3* |
| Lung and Bronchus | 31.9 | -3.2* | |
| Prostate | 18.5 | -3.4* | |
| Colon and Rectum | 15.5 | -2.2* | |
| Liver & IBDf | 11.6 | 1.5* | |
| Pancreas | 9.2 | 0.3 | |
| Stomach | 7.7 | -3.7* | |
| Non-Hodgkin Lymphoma | 6.3 | -2.5* | |
| Leukemia | 6.0 | -1.6* | |
| Kidney and Renal Pelvis | 5.2 | -0.7 | |
| Esophagus | 4.1 | -1.1 | |
| Urinary Bladder | 3.8 | -1.5 | |
| Myeloma | 3.3 | -2.1 | |
| Brain and ONSf | 3.2 | -0.9 | |
| Oral Cavity and Pharynx | 2.4 | -3.2* | |
| Larynx | 1.8 | -3.7* |
Footnotes:
a Top 15 cancer sites selected based on 2004-2008 age-adjusted rates for the race/ethnic group.
b Mortality data used in calculating the rates are analyzed from US mortality files provided by the National Center for Health Statistics, CDC. Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130).
c The APC is the Annual Percent Change over the time interval. Mortality data used in calculating the trends are analyzed from US mortality files provided by the National Center for Health Statistics, CDC. Trends are based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130).
d Rates for American Indian/Alaska Native are based on the CHSDA(Contract Health Service Delivery Area) counties.
e Hispanic is not mutually exclusive from whites, blacks, Asian/Pacific Islanders, and American Indians/Alaska Natives. The 2004-2008 Hispanic death rates do not include deaths from the District of Columbia and North Dakota. The 1999-2008 Hispanic mortality trends do not include deaths from the District of Columbia, Minnesota, New Hampshire and North Dakota.
f IBD = Intrahepatic Bile Duct. ONS = Other Nervous System.
* The APC is significantly different from zero (p<.05).
- Statistic not shown. Rate based on less than 16 cases for the time interval. Trend based on less than 10 cases for at least one year within the time interval.
Page Navigation: << Previous Next >>
The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.